Women in medicine need sponsorship from key physician leaders to advance their careers and address historic gender ...

Open-label placebo yielded very modest analgesia in chronic low back pain, with better short- vs long-term outcomes.

The FDA has approved Tremfya (guselkumab) for the treatment of adults with moderately to severely active Crohn disease.

HealthDay News — The U.S. Food and Drug Administration has launched the Chemical Contaminants Transparency Tool (CCT Tool), an online searchable database to evaluate potential health risks of ...

Moderate intensity aerobic + resistance exercise did not lead to superior pain and function outcomes in patients with hip OA, compared with resistance exercise alone.

Researchers identified 4 prepregnancy conditions that were associated with better pregnancy outcomes among patients with SLE.

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

Asthma is linked to an increased risk of developing knee, hip, and hand OA, particularly among patients with higher social isolation and loneliness.

High ionized calcium levels were associated with an increased risk for hyperparathyroidism, especially among men.

Relative to high-dose doxycycline, low-dose doxycycline is comparably effective but more tolerable for lymphocytic scarring alopecias.

HealthDay News — The total number of births in the United States in 2023 was 3,596,017, which was down 2 percent from 2022, according to the March 18 National Vital Statistics Reports, a publication ...

Topline data were announced from pivotal phase 3 studies evaluating povorcitinib in adults with moderate to severe hidradenitis suppurativa.